Green Energy Act Finance Forum: Taking cleantech to Bay Street

Posted by Tom @ MaRS, February 8th, 2010

GEAFF - Green Energy Finance Forum

Outcomes of the Green Energy Finance Forum

Last Friday saw an extraordinary number of Ontario’s financiers in the MaRS auditorium. Why? The Green Energy Act has brought into being an entirely new class of financial asset: financing Feed-in Tariff based renewable energy projects. In easy terms: the FIT guarantees a good rate of return for wind, solar, hydro and biogas projects. It’s like a government guaranteed bond that pays upward of 10%.

On Friday, MaRS was educating Bay Street about the opportunity. The message: renewable energy projects are no longer a fringe play; they’re a strong, mainstream finance opportunity.




Canadian biotech balance sheet

Posted by John Mc @ MaRS, February 5th, 2010

Money in the biotech industry

Money for the biotech industry?

BIOTECanada has made further announcements on the financial condition of the Canadian biotechnology industry.

A recent survey indicated that 70% of Canadian biotech companies have at least a year of cash on hand versus a mere 30% in July 2009.  According to the January 25 news release this turnaround was achieved by companies restructuring their operations (read “downsizing”) and increased access to foreign investment (read “fire sale”). With the important proviso that I haven’t seen the underlying survey data, I can’t help but wonder if the upswing in apparent financial viability was driven by closures of less financially fit companies than any genuine positive momentum.




Tune in to MaRS Future of Medicine™ Television!

Posted by John Mc @ MaRS, February 3rd, 2010

Future of Medicine TV

Watch MaRS Future of Medicine™ TV

Announcing the MaRS Future of Medicine™ online video channel highlighting outstanding presentations from the inaugural MaRS Future of Medicine™ Conference held in Toronto on November 12, 2009.

The mission of MaRS Future of Medicine™ is to showcase Ontario’s leading life sciences innovations, share best practices for commercial development and help facilitate industry partnership and investment. If you missed the sessions or just want a refresh, tune in now!




Good enough is the new perfect?: Deloitte’s Technology Predictions 2010

Posted by Keri @ MaRS, January 29th, 2010

Books aren't dead: They're just going digital

Consumers turn to the Kindle

A new year, a new set of technology predictions from Deloitte. Last Wednesday, Deloitte unveiled their annual TMT (technology, media and telecommunications) predictions for 2010 at MaRS and looked back on how their 2009 predictions fared.

Most notable of their 2009 predictions were the rise of netbooks, social networks, smart phones and 3D in theatres and on TV (think Avatar and all the new 3D electronics from Sony and Samsung among others at CES 2010). They were also awfully close on their prediction that one in 10 newspapers in the US would die in 2009 – the actual statistic was one in 12.

This year, the theme was “good enough becomes better than perfect” – meaning that we still want our data anywhere and anytime, but we want to access it economically (and we don’t necessarily need the best device to do it).

So what does Deloitte think that 2010 has in store for technology?  Here’s a sampling from their Top 10 Canadian TMT Predictions for 2010:




Leukemia gets a boost

Posted by John Mc @ MaRS, January 28th, 2010

Science Buzz

What's the buzz on cord blood stem cells?

Dr. Colleen Delaney and colleagues at Seattle’s Fred Hutchinson Cancer Research Center published a significant breakthrough relating to new treatment options for acute leukemia and other blood cancers this month in  Nature Medicine journal.

Promising news for cord blood stem cell applications.




Popular Tags

Read Up

Feds boost venture capital  (1)
  • Paul Wilson: I applaud the Canadian federal government for increasing it's investment pool but Canadian...
CIBC Presents Entrepreneurship 101: Shooting for gold (4)
  • halayc: I took this with me from this lecture: “It takes 10 years to become an overnight success” and...
One-step diabetes cure (2)
  • davee44: Actually the Danish Pharma company Novo is set to release a new diabetes medication. It should be on the...
Better The World: A summary (1)
  • Ryan Coelho: The Top 10 Lessons learnt are great! Thanks Steve!Please register Ryan Coelho for this session.Thanks.
Canadian biotech balance sheet (1)
  • Tim Tang: A balance sheet is a good snapshot of a business, but it's only a snapshot. Regardless of the industry,...

MaRS on the web



About The MaRS Blog

Monthly Archives

Yearly Archives